Literature DB >> 31879505

From Real-World Evidence to Consensus of Renal Denervation in Taiwan: A Call for the Incorporation of Ambulatory Blood Pressure Monitoring after Witnessed Intake of Medications.

Tzung-Dau Wang1.   

Abstract

Year:  2019        PMID: 31879505      PMCID: PMC6859099          DOI: 10.6515/ACS.201911_35(6).20191103A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  31 in total

1.  The Relationship between Serum Apelin Levels and the Severity of Calcific Aortic Stenosis.

Authors:  Hakan Duman; Ilkay Bahçeci; Hikmet Hamur; Selami Demirelli; Aziz Ramazan Dilek; Turan Erdogan; Handan Duman; Ömer Şatıroğlu; Murtaza Emre Durakoğlugil
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

2.  Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan - Safety and Efficacy of Renal Denervation at 3 Years.

Authors:  Kazuomi Kario; Eiichiro Yamamoto; Hirofumi Tomita; Takafumi Okura; Shigeru Saito; Takafumi Ueno; Daiki Yasuhara; Kazuyuki Shimada
Journal:  Circ J       Date:  2019-02-13       Impact factor: 2.993

3.  Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.

Authors:  Fadl Elmula Mohamed Fadl Elmula; Pavel Hoffmann; Eigil Fossum; Magne Brekke; Eyvind Gjønnæss; Ulla Hjørnholm; Vibeke N Kjær; Morten Rostrup; Sverre E Kjeldsen; Ingrid Os; Aud-E Stenehjem; Aud Høieggen
Journal:  Hypertension       Date:  2013-07-08       Impact factor: 10.190

4.  Acute Hemodynamic Effects of Remote Ischemic Preconditioning on Coronary Perfusion Pressure and Coronary Collateral Blood Flow in Coronary Heart Disease.

Authors:  Yuansheng Xu; Qinkai Yu; Jianmin Yang; Fang Yuan; Yigang Zhong; Zhanlin Zhou; Ningfu Wang
Journal:  Acta Cardiol Sin       Date:  2018-07       Impact factor: 2.672

5.  Coronary Artery Dominance May Predict Future Risk of Atrial Fibrillation.

Authors:  Abdullah Nabi Aslan; Serdal Baştuğ; Hacı Ahmet Kasapkara; Murat Can Güney; Serkan Sivri; Engin Bozkurt
Journal:  Acta Cardiol Sin       Date:  2018-07       Impact factor: 2.672

6.  Comparison of Ultrasound Guidance and Conventional Method for Common Femoral Artery Cannulation: A Prospective Study of 939 Patients.

Authors:  Mahmut Tuna Katırcıbaşı; Hakan Güneş; Ahmet Çağrı Aykan; Ekrem Aksu; Sami Özgül
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

7.  Blood Pressure Reactivity and Recovery to Anger Recall in Hypertensive Patients with Type D Personality.

Authors:  Yi-Da Li; Tin-Kwang Lin; Yi-Ru Tu; Chih-Wei Chen; Chin-Lon Lin; Ming-Nan Lin; Malcolm Koo; Chia-Ying Weng
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

8.  Effect of Heart Rate-Oriented Therapy on Diastolic Functions in Patients with Heart Failure with Reduced Ejection Fraction.

Authors:  Sedat Taş; Ümmü Taş; Ebru Özpelit; Efe Edem; Bahri Akdeniz
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

9.  May Measurement Month 2017: Results from Taiwan-East Asia.

Authors:  Hung-Ju Lin; Heng-Yu Pan; Elsa Kobeissi; Thomas Beaney; Neil R Poulter; Wen-Jone Chen; Tzung-Dau Wang
Journal:  Eur Heart J Suppl       Date:  2019-04-24       Impact factor: 1.803

10.  Bendopnea and Its Clinical Importance in Outpatient Patients with Pulmonary Arterial Hypertension.

Authors:  Kurtulus Karauzum; Irem Karauzum; Teoman Kilic; Tayfun Sahin; Canan Baydemir; Serap Baris Argun; Umut Celikyurt; Ulas Bildirici; Aysen Agir
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

View more
  1 in total

1.  Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Kang-Ling Wang; Chih-Yuan Fang; Wen-Ter Lai; Tzung-Dau Wang; Kwo-Chang Ueng; Kuo-Yang Wang; Ji-Hung Wang; Kou-Gi Shyu; Chern-En Chiang
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.